Alzamend Neuro, Inc.

ALZN ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $631.6K

Liabilities Breakdown FY2024

Total Liabilities: $3.2M